FDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions; The FDA had been expected to approve Neffy nasal spray based on the recommendation of an advisory panel.

Media coverage

• Title	FDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions; The FDA had been expected to approve Neffy nasal spray based on the recommendation of an advisory panel.
  Media name/outlet	Physician's Briefings
  Country/Territory	United States
  Date	20/09/23
  Persons	Scott Sicherer